YLYe Liu

Ye Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ye Liu has a total of 23 co-authors. Here are the top co-authors by number of shared publications:

  • Guohui Li

    Interdisciplinary Research Center for Biology and Chemistry, Liaoning Normal University, Dalian, China

    4 shared publications
  • Huiying Chu

    Interdisciplinary Research Center for Biology and Chemistry, Liaoning Normal University, Dalian, China

    4 shared publications
  • Chengrui Shi

    School of Pharmaceutical Sciences, Key Laboratory of Bioorganic Phosphorous Chemistry and Chemical Biology (Ministry of Education), Department of Chemistry, Tsinghua University, Beijing 100084, China

    1 shared publication
  • Dong Hui Zhang

    Dalian Institute of Chemical Physics, Chinese Academy of Sciences

    1 shared publication
  • Hang Yin

    State Key Laboratory of Membrane Biology, School of Pharmaceutical Sciences, Tsinghua-Peking Center for Life Sciences, Tsinghua University

    1 shared publication
  • Haojiang Yao

    School of Chemistry and Materials Science, University of Science and Technology of China, Hefei, 230026, China

    1 shared publication

Latest Publications

  • Investigating the molecular mechanism of selective inhibition of JAK1/TYK2 by SOCS1/SOCS3 using molecular dynamics simulations

    by Xinmiao Zhai, Yan Li, Yong-Biao Yang, Ye Liu, Huiying Chu

    Aberrant activation of the Janus kinase/Signal Transducer and Activator of Transcription (JAK/STAT) signaling pathway is associated with various pathological conditions.

  • Open Access

    Solvent–temperature coupled hydride transfer controls product selectivity in the HSiR 3 /KO t Bu catalytic system

    by Haojiang Yao, Zhenhao Zhou, Ye Liu, Dong Hui Zhang, Guo-Hui Li

    The HSiR 3 /KO t Bu catalytic system affords a notable regioselective C–H silylation reaction using alkaline earth metals, yet its mechanistic origins and the temperature-dependent selectivity inversion remain unresolved.


  • NIT2 dampens BRD1 phase separation and restrains oxidative phosphorylation to enhance chemosensitivity in gastric cancer

    by Ziyang Wang, Yuqin Di, Xiangqiong Wen, Ye Liu, Lvlan Ye, Xiang Zhang, Jiale Qin, Youpeng Wang, Huiying Chu, Guohui Li, et al.

    5-Fluorouracil (5-FU) chemoresistance contributes to poor therapeutic response and prognosis of gastric cancer (GC), for which effective strategies to overcome chemoresistance are limited. Here, using a CRISPR-Cas9 system, we identified that nitrilase family member 2 (NIT2) reverses chemoresistance independent of its metabolic function. Depletion or low expression of NIT2 led to 5-FU resistance in GC cell lines, patient-derived organoids, and xenografted tumors. Mechanistically, NIT2 interacted with bromodomain-containing protein 1 (BRD1) to inhibit HBO1-mediated acetylation of histone H3 at lysine-14 (H3K14ac) and RELA-targeted oxidative phosphorylation (OXPHOS) gene expression. Upon 5-FU stimulation, NIT2 phosphorylation by Src at Y49 promoted the dissociation of NIT2 from BRD1, followed by binding to E3 ligase CCNB1IP1, causing autophagic degradation of NIT2. Consequently, reduced NIT2 protein resulted in BRD1 forming phase separation and binding to histone H3, as well as increased RELA stability due to suppression of inhibitor of growth family member 4–mediated RELA ubiquitination. In addition, NIT2 expression negatively correlated with H3K14ac and OXPHOS and positively correlated with the chemotherapeutic responses and prognosis of patients with GC. Our findings reveal the moonlighting function of NIT2 in chemoresistance and underscore that OXPHOS blockade by metformin enhances 5-FU chemosensitivity upon NIT2 loss.


  • The molecular mechanism of Y473 phosphorylation of UGDH relieves the inhibition effect of UDP-glucose on HuR

    by Ye Liu, Yan Li, Guohui Li, Huiying Chu

    Uridine diphosphate glucose (UDP-Glc) is able to accelerate the decay of snail family transcriptional repressor 1 (SNAI1) mRNA by inhibiting Hu antigen R (HuR, an RNA-binding protein), thereby preventing cancer invasiveness and drug resistance. Nevertheless, the phosphorylation of tyrosine 473 (Y473) of UDP-glucose dehydrogenase (UGDH is capable of converting UDP-Glc to uridine diphosphate glucuronic acid (UDP-GlcUA)) weakens the inhibition of UDP-Glc to HuR, thus initiating the epithelial-mesenchymal transformation of tumor cells and promoting tumor cell migration and metastasis. To address the mechanism, we performed molecular dynamics simulations combined with molecular mechanics generalized Born surface area (MM/GBSA) analysis on wild-type and Y473 phosphorylated UGDH and HuR, UDP-Glc, UDP-GlcUA complexes. We demonstrated that Y473 phosphorylation was able to enhance the binding between UGDH and the HuR/UDP-Glc complex. Compared with HuR, UGDH has a stronger binding ability with UDP-Glc; therefore, UDP-Glc was inclined to bind to UGDH and then was catalyzed to UDP-GlcUA by UGDH, which relieved the inhibition of UDP-Glc to HuR. In addition, the binding ability of HuR for UDP-GlcUA was lower than its affinity for UDP-Glc, significantly reducing the inhibition of HuR. Hence, HuR bound to SNAI1 mRNA more easily to increase the stability of mRNA. Our results revealed the micromolecular mechanism of Y473 phosphorylation of UGDH regulating the interaction between UGDH and HuR as well as relieving the inhibition of UDP-Glc on HuR, which contributed to understanding the role of UGDH and HuR in tumor metastasis and developing small molecule drugs targeting the interaction between UGDH and HuR.


  • ZDHHC18 negatively regulates cGAS‐mediated innate immunity through palmitoylation

    by Chengrui Shi, Xikang Yang, Ye Liu, Hongpeng Li, Huiying Chu, Guohui Li, Hang Yin

    Double‐stranded DNA is recognized as a danger signal by cyclic guanosine monophosphate‐adenosine monophosphate synthase (cGAS), triggering innate immune responses. Palmitoylation is an important post‐translational modification (PTM) catalyzed by DHHC‐palmitoyl transferases, which participate in the regulation of diverse biological processes. However, whether palmitoylation regulates cGAS function has not yet been explored. Here, we found that palmitoylation of cGAS at C474 restricted its enzymatic activity in the presence of double‐stranded DNA. cGAS palmitoylation was catalyzed mainly by the palmitoyltransferase ZDHHC18 and double‐stranded DNA promoted this modification. Mechanistically, palmitoylation of cGAS reduced the interaction between cGAS and double‐stranded DNA, further inhibiting cGAS dimerization. Consistently, ZDHHC18 negatively regulated cGAS activation in human and mouse cell lines. In a more biologically relevant model system, Zdhhc18‐deficient mice were found to be resistant to infection by DNA viruses, in agreement with the observation that ZDHHC18 negatively regulated cGAS mediated innate immune responses in human and mouse primary cells. In summary, the negative role of ZDHHC18‐mediated cGAS palmitoylation may be a novel regulatory mechanism in the fine‐tuning of innate immunity.